GAPDHP50

Across TCGA pan-cancer cohorts, GAPDHP50 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated GAPDHP50 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher GAPDHP50 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated GAPDHP50 expression acts as an unfavorable survival marker.

UCS, OV, and BRCA are the cancer types where GAPDHP50 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	All	0.225	0.695	.005	108	view →
OV	DFS	Tertile	All	0.232	0.389	.001	90	view →
BRCA	DFS	Tertile	All	0.786	0.951	<.001	54	view →
KIRC	OS	Tertile	All	0.393	0.658	<.001	48	view →
STAD	DFS	Tertile	All	0.554	0.687	.009	42	view →
PAAD	OS	Tertile	All	0.226	0.599	<.001	36	view →
LUAD	OS	Tertile	All	0.150	0.371	.003	36	view →
LUSC	OS	Tertile	All	0.302	0.751	<.001	36	view →
LIHC	OS	Tertile	All	0.207	0.580	.004	24	view →
GBM	DFS	Tertile	All	0.106	0.248	.025	18	view →
ACC	DFS	Tertile	All	0.129	0.771	<.001	18	view →
KIRP	OS	Tertile	III,IV	0.268	0.808	.012	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

GAPDHP50–UCS (OS)

Open the UCS breakdown →